{"id":1031099,"date":"2013-06-14T09:33:10","date_gmt":"2013-06-14T13:33:10","guid":{"rendered":"http:\/\/www.immortalitymedicine.tv\/human-reproduction\/placental-protein-13-pp13-a-new-biological-target-shifting-individualized-risk-assessment-to-personalized-drug-design-combating-pre-eclampsia.php"},"modified":"2024-08-17T15:03:39","modified_gmt":"2024-08-17T19:03:39","slug":"placental-protein-13-pp13-a-new-biological-target-shifting-individualized-risk-assessment-to-personalized-drug-design-combating-pre-eclampsia","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/human-reproduction\/placental-protein-13-pp13-a-new-biological-target-shifting-individualized-risk-assessment-to-personalized-drug-design-combating-pre-eclampsia.php","title":{"rendered":"Placental protein 13 (PP13): a new biological target shifting individualized risk assessment to personalized drug design combating pre-eclampsia"},"content":{"rendered":"<p>Background<\/p>\n<p>Pre-eclampsia affects 2&ndash;7% of all pregnant women and is a major cause of maternal and fetal morbidity and mortality. The etiology of pre-eclampsia is still unknown but it is well documented that impaired placentation is a major contributor to its development. One of the placenta-specific proteins is placental protein 13 (PP13). Lower first trimester levels of maternal serum PP13 and its encoding placental mRNA are associated with the development of both early and late-onset severe pre-eclampsia. In cases where this protein is mutated, the frequency of pre-eclampsia is higher.  <\/p>\n<p>Methods<\/p>\n<p>19 out of 68 studies on PP13, published between January 2006 and September 2012, were used to evaluate the value of maternal blood PP13 as a marker of pre-eclampsia.<\/p>\n<p>Results<\/p>\n<p>A meta-analysis presented in this review shows that low serum levels of PP13 in the first trimester of pregnancy can predict the development of pre-eclampsia later in pregnancy. Although some functions of this protein have been assessed in <I>in vitro<\/I> experiments, the <I>in vivo<\/I> functions of PP13 are still unknown, especially when circulating in the maternal bloodstream. A recent pilot study has shown that in gravid rats PP13 causes significant vasodilatation, reduced blood pressure and increased maternal uterine artery remodeling.<\/p>\n<p>Conclusion<\/p>\n<p>Reviewing these effects of PP13, the authors propose the use of PP13 as a new drug candidate. Replenishing PP13 in those women with low serum levels early in pregnancy may help prepare their vasculature for pregnancy. This novel pharmacological approach to combat pre-eclampsia is presented as a new direction to transfer from individualized risk to personalized prevention.<\/p>\n<p>Source:<br \/><a href=\"http:\/\/humupd.oxfordjournals.org\/cgi\/content\/short\/19\/4\/391?rss=1\">http:\/\/humupd.oxfordjournals.org\/cgi\/content\/short\/19\/4\/391?rss=1<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Background Pre-eclampsia affects 2&ndash;7% of all pregnant women and is a major cause of maternal and fetal morbidity and mortality. The etiology of pre-eclampsia is still unknown but it is well documented that impaired placentation is a major contributor to &hellip; <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/human-reproduction\/placental-protein-13-pp13-a-new-biological-target-shifting-individualized-risk-assessment-to-personalized-drug-design-combating-pre-eclampsia.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246857],"tags":[],"class_list":["post-1031099","post","type-post","status-publish","format-standard","hentry","category-human-reproduction"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1031099"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1031099"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1031099\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1031099"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1031099"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1031099"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}